The National Institutes of Health (NIH) has posted a grant opportunity titled "Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)". This grant aims to support research that enhances the capacity, transformation, and scalability of HIV testing, prevention, and care services provided by pharmacists and pharmacies in both US and global settings. The goal is to develop training curricula that enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver a comprehensive range of HIV services with ease, equity, and effectiveness. The R21 grant mechanism will be used for projects that lack preliminary data or propose to pilot a novel intervention. On the other hand, projects with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism. The grant does not require cost sharing or matching. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The close date for this grant opportunity is August 13, 2024. For more information and to apply, visit the following link: Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.